Services
Index from A to Z
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z |
| Accounting standards |
| Acquisitions |
| Acquisition accounting |
| Annual Stockholders' Meeting |
| Asset structure |
| Associates |
| Audit Committee |
| Audit fees |
| Auditor |
| Awards |
| Balance sheet |
| Bayer Business Services |
| Bayer CropScience |
| Bayer HealthCare |
| Currenta |
| Bayer Innovation GmbH |
| Bayer MaterialScience |
| Bayer stock |
| Bayer stock data |
| Bayer Technology Services |
| Board of Management |
| Bonds |
| Business environment |
| Business strategy |
| Capital expenditures |
| Capital structure |
| Cash flow |
| Changes in stockholders' equity |
| Changes in Bayer Group |
| Commitments and contingencies |
| Compliance Committee |
| Consolidated statements of cash flows |
| Consolidation methods |
| Contact |
| Corporate citizen |
| Corporate Compliance Program |
| Corporate governance |
| Corporate Governance Code |
| Corporate social responsibility |
| Corporate structure |
| Critical accounting policies |
| Currency risk |
| Currency translation |
| Derivative financial instruments |
| Discontinued operations |
| Distribution |
| Divestitures |
| Dividend |
| Earnings performance |
| Earnings per share |
| Economic hedges |
| Economic outlook |
| Employees |
| Environmental protection |
| Exchange rates |
| Exchange rate risk |
| Fair value |
| Financial calendar |
| Financial instruments |
| Financial liabilities |
| Financial position |
| Financial risks |
| Financial strategy |
| Five-year financial summary |
| Future perspectives |
| Glossary |
| Goodwill |
| Governance bodies |
| Group Leadership Circle |
| Hedge accounting |
| Highlights |
| Human Resources Committee |
| Impairment |
| Impairment testing |
| Income statements |
| Income taxes |
| Independent Auditor's Report |
| Indices |
| Innovation and growth |
| Intangible assets |
| Interest expense – net |
| Interest rate risk |
| Inventories |
| Investor relations |
| Key data by segment and region |
| Key data by subgroup |
| Key performance indicators |
| Lanxess |
| Leasing |
| Legal risks |
| Management report |
| Management's statement of responsibility for financial reporting |
| Minority stockholders' interest in income/expense |
| Mission Statement |
| Net debt |
| Net income |
| News |
| Non-operating result |
| Notes to the consolidated financial statements |
| Objectives for 2006 |
| Organization chart |
| Other financial assets |
| Other financial commitments |
| Other non-operating expence |
| Other non-operating income |
| Other operating expence |
| Other operating income |
| Other receivables |
| Pensions |
| Performance by region |
| Performance by subgroup |
| Personnel expenses |
| Portfolio management |
| Presidial Committee |
| Primary financial instruments |
| Procurement and distribution |
| Procurement market risk |
| Property, plant and equipment |
| Proposal for distribution of the profit |
| Provisions |
| Provisions for pensions and other post-employment benefits |
| R&D expenses |
| Recognition and valuation principles |
| Regions |
| Remuneration of the Board of Management |
| Remuneration of the Supervisory Board |
| Research and development |
| Responsible Care |
| Restructuring charges |
| Risk management |
| Salaries (see Remuneration) |
| Sales |
| Scope of consolidation |
| Segment reporting |
| Segments |
| Selling expenses |
| Share price |
| Statement of recognized income and expense |
| Stock-based compensation |
| Stockholders' equity |
| Strategy |
| Subsequent events |
| Supervisory Board |
| Sustainability |
| Sustainable development |
| Sustainable investment |
| Taxes |
| Trade accounts payable |
| Trade accounts receivable |
| UNEP |
| Value management |

Chairman’s Letter
Index from A to Z
Bayer Links

Bookmark this page
E-mail this page
Advanced Search

